Список проголосовавших за комментарий " On The Wires<ul><li>Cancer Genetics (<strong>CGIX</strong>) announced today the successful CLIA validation and approval of its immuno-oncology assay on Complete::IO.</li><li>ATyr Pharma (<strong>LIFE</strong>) obtained promising clinical results from its Phase 1b/2 003 trial assessing the safety and potential activity of Resolari in patients with early onset facioscapulohumeral muscular dystrophy.<ul><li>63% of Patients Observed Increased Muscle Strength</li><li>67% of patients measured had improvement in their Individualized Neuromuscular Quality of Life score</li></ul></li><li>Akers Biosciences (<strong>AKER</strong>) Akers Wellness app, which enables users to track the results of breath-based tests via their mobile device has been approved by the Apple App Store and is now available for download on iOS devices.</li><li>Global Payments (<strong>GPN</strong>) agreed to renew its relationship with Caesars Entertainment Corporation (<strong>CZR</strong>). Terms not disclosed.</li></ul>"